Global Pulmonary Edema Treatment Market Research Report 2023

Pulmonary edema refers to the generation and reflux imbalance of tissue fluid in the lung caused by some reasons, so that a large number of tissue fluid in a very short period of time can not be absorbed by the pulmonary lymphatic and pulmonary vein system, from the pulmonary capillary osmosis, accumulated in the alveoli, lung interstitium and small bronchial, resulting in pulmonary ventilation and ventilation function serious obstacles.

The global Pulmonary Edema Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Pulmonary Edema Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Pulmonary Edema Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Pulmonary Edema Treatment in Hospitals and Clinics is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Pulmonary Edema Treatment include Pfizer Inc (US), ARGON MEDICAL (US), Edwards Lifesciences Corporation (US), BD (US), Alcaliber S.A. (Spain), Lupin Pharmaceuticals (India), Vitaltec Corporation (China), Medtronic (US) and Koninklijke Philips N.V. (The Netherlands), etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Pulmonary Edema Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pulmonary Edema Treatment.

The Pulmonary Edema Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pulmonary Edema Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pulmonary Edema Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Pfizer Inc (US)

ARGON MEDICAL (US)

Edwards Lifesciences Corporation (US)

BD (US)

Alcaliber S.A. (Spain)

Lupin Pharmaceuticals (India)

Vitaltec Corporation (China)

Medtronic (US)

Koninklijke Philips N.V. (The Netherlands)

Siemens Healthcare (Germany)

Hitachi Medical Corporation (US)

Canon Medical Systems Corporation (Japan)

Diagnosis

Treatment

Hospitals and Clinics

Academic Institutes

Retail Pharmacies

Household

Other

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pulmonary Edema Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pulmonary Edema Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Diagnosis

1.2.3 Treatment

1.3 Market by Application

1.3.1 Global Pulmonary Edema Treatment Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals and Clinics

1.3.3 Academic Institutes

1.3.4 Retail Pharmacies

1.3.5 Household

1.3.6 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Pulmonary Edema Treatment Market Perspective (2018-2029)

2.2 Pulmonary Edema Treatment Growth Trends by Region

2.2.1 Global Pulmonary Edema Treatment Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Pulmonary Edema Treatment Historic Market Size by Region (2018-2023)

2.2.3 Pulmonary Edema Treatment Forecasted Market Size by Region (2024-2029)

2.3 Pulmonary Edema Treatment Market Dynamics

2.3.1 Pulmonary Edema Treatment Industry Trends

2.3.2 Pulmonary Edema Treatment Market Drivers

2.3.3 Pulmonary Edema Treatment Market Challenges

2.3.4 Pulmonary Edema Treatment Market Restraints

3.1 Global Top Pulmonary Edema Treatment Players by Revenue

3.1.1 Global Top Pulmonary Edema Treatment Players by Revenue (2018-2023)

3.1.2 Global Pulmonary Edema Treatment Revenue Market Share by Players (2018-2023)

3.2 Global Pulmonary Edema Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pulmonary Edema Treatment Revenue

3.4 Global Pulmonary Edema Treatment Market Concentration Ratio

3.4.1 Global Pulmonary Edema Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pulmonary Edema Treatment Revenue in 2022

3.5 Pulmonary Edema Treatment Key Players Head office and Area Served

3.6 Key Players Pulmonary Edema Treatment Product Solution and Service

3.7 Date of Enter into Pulmonary Edema Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Pulmonary Edema Treatment Historic Market Size by Type (2018-2023)

4.2 Global Pulmonary Edema Treatment Forecasted Market Size by Type (2024-2029)

5.1 Global Pulmonary Edema Treatment Historic Market Size by Application (2018-2023)

5.2 Global Pulmonary Edema Treatment Forecasted Market Size by Application (2024-2029)

6.1 North America Pulmonary Edema Treatment Market Size (2018-2029)

6.2 North America Pulmonary Edema Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Pulmonary Edema Treatment Market Size by Country (2018-2023)

6.4 North America Pulmonary Edema Treatment Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Pulmonary Edema Treatment Market Size (2018-2029)

7.2 Europe Pulmonary Edema Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Pulmonary Edema Treatment Market Size by Country (2018-2023)

7.4 Europe Pulmonary Edema Treatment Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Pulmonary Edema Treatment Market Size (2018-2029)

8.2 Asia-Pacific Pulmonary Edema Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Pulmonary Edema Treatment Market Size by Region (2018-2023)

8.4 Asia-Pacific Pulmonary Edema Treatment Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Pulmonary Edema Treatment Market Size (2018-2029)

9.2 Latin America Pulmonary Edema Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Pulmonary Edema Treatment Market Size by Country (2018-2023)

9.4 Latin America Pulmonary Edema Treatment Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Pulmonary Edema Treatment Market Size (2018-2029)

10.2 Middle East & Africa Pulmonary Edema Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Pulmonary Edema Treatment Market Size by Country (2018-2023)

10.4 Middle East & Africa Pulmonary Edema Treatment Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Pfizer Inc (US)

11.1.1 Pfizer Inc (US) Company Detail

11.1.2 Pfizer Inc (US) Business Overview

11.1.3 Pfizer Inc (US) Pulmonary Edema Treatment Introduction

11.1.4 Pfizer Inc (US) Revenue in Pulmonary Edema Treatment Business (2018-2023)

11.1.5 Pfizer Inc (US) Recent Development

11.2 ARGON MEDICAL (US)

11.2.1 ARGON MEDICAL (US) Company Detail

11.2.2 ARGON MEDICAL (US) Business Overview

11.2.3 ARGON MEDICAL (US) Pulmonary Edema Treatment Introduction

11.2.4 ARGON MEDICAL (US) Revenue in Pulmonary Edema Treatment Business (2018-2023)

11.2.5 ARGON MEDICAL (US) Recent Development

11.3 Edwards Lifesciences Corporation (US)

11.3.1 Edwards Lifesciences Corporation (US) Company Detail

11.3.2 Edwards Lifesciences Corporation (US) Business Overview

11.3.3 Edwards Lifesciences Corporation (US) Pulmonary Edema Treatment Introduction

11.3.4 Edwards Lifesciences Corporation (US) Revenue in Pulmonary Edema Treatment Business (2018-2023)

11.3.5 Edwards Lifesciences Corporation (US) Recent Development

11.4 BD (US)

11.4.1 BD (US) Company Detail

11.4.2 BD (US) Business Overview

11.4.3 BD (US) Pulmonary Edema Treatment Introduction

11.4.4 BD (US) Revenue in Pulmonary Edema Treatment Business (2018-2023)

11.4.5 BD (US) Recent Development

11.5 Alcaliber S.A. (Spain)

11.5.1 Alcaliber S.A. (Spain) Company Detail

11.5.2 Alcaliber S.A. (Spain) Business Overview

11.5.3 Alcaliber S.A. (Spain) Pulmonary Edema Treatment Introduction

11.5.4 Alcaliber S.A. (Spain) Revenue in Pulmonary Edema Treatment Business (2018-2023)

11.5.5 Alcaliber S.A. (Spain) Recent Development

11.6 Lupin Pharmaceuticals (India)

11.6.1 Lupin Pharmaceuticals (India) Company Detail

11.6.2 Lupin Pharmaceuticals (India) Business Overview

11.6.3 Lupin Pharmaceuticals (India) Pulmonary Edema Treatment Introduction

11.6.4 Lupin Pharmaceuticals (India) Revenue in Pulmonary Edema Treatment Business (2018-2023)

11.6.5 Lupin Pharmaceuticals (India) Recent Development

11.7 Vitaltec Corporation (China)

11.7.1 Vitaltec Corporation (China) Company Detail

11.7.2 Vitaltec Corporation (China) Business Overview

11.7.3 Vitaltec Corporation (China) Pulmonary Edema Treatment Introduction

11.7.4 Vitaltec Corporation (China) Revenue in Pulmonary Edema Treatment Business (2018-2023)

11.7.5 Vitaltec Corporation (China) Recent Development

11.8 Medtronic (US)

11.8.1 Medtronic (US) Company Detail

11.8.2 Medtronic (US) Business Overview

11.8.3 Medtronic (US) Pulmonary Edema Treatment Introduction

11.8.4 Medtronic (US) Revenue in Pulmonary Edema Treatment Business (2018-2023)

11.8.5 Medtronic (US) Recent Development

11.9 Koninklijke Philips N.V. (The Netherlands)

11.9.1 Koninklijke Philips N.V. (The Netherlands) Company Detail

11.9.2 Koninklijke Philips N.V. (The Netherlands) Business Overview

11.9.3 Koninklijke Philips N.V. (The Netherlands) Pulmonary Edema Treatment Introduction

11.9.4 Koninklijke Philips N.V. (The Netherlands) Revenue in Pulmonary Edema Treatment Business (2018-2023)

11.9.5 Koninklijke Philips N.V. (The Netherlands) Recent Development

11.10 Siemens Healthcare (Germany)

11.10.1 Siemens Healthcare (Germany) Company Detail

11.10.2 Siemens Healthcare (Germany) Business Overview

11.10.3 Siemens Healthcare (Germany) Pulmonary Edema Treatment Introduction

11.10.4 Siemens Healthcare (Germany) Revenue in Pulmonary Edema Treatment Business (2018-2023)

11.10.5 Siemens Healthcare (Germany) Recent Development

11.11 Hitachi Medical Corporation (US)

11.11.1 Hitachi Medical Corporation (US) Company Detail

11.11.2 Hitachi Medical Corporation (US) Business Overview

11.11.3 Hitachi Medical Corporation (US) Pulmonary Edema Treatment Introduction

11.11.4 Hitachi Medical Corporation (US) Revenue in Pulmonary Edema Treatment Business (2018-2023)

11.11.5 Hitachi Medical Corporation (US) Recent Development

11.12 Canon Medical Systems Corporation (Japan)

11.12.1 Canon Medical Systems Corporation (Japan) Company Detail

11.12.2 Canon Medical Systems Corporation (Japan) Business Overview

11.12.3 Canon Medical Systems Corporation (Japan) Pulmonary Edema Treatment Introduction

11.12.4 Canon Medical Systems Corporation (Japan) Revenue in Pulmonary Edema Treatment Business (2018-2023)

11.12.5 Canon Medical Systems Corporation (Japan) Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Pulmonary Edema Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Diagnosis

    Table 3. Key Players of Treatment

    Table 4. Global Pulmonary Edema Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Pulmonary Edema Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Pulmonary Edema Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Pulmonary Edema Treatment Market Share by Region (2018-2023)

    Table 8. Global Pulmonary Edema Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Pulmonary Edema Treatment Market Share by Region (2024-2029)

    Table 10. Pulmonary Edema Treatment Market Trends

    Table 11. Pulmonary Edema Treatment Market Drivers

    Table 12. Pulmonary Edema Treatment Market Challenges

    Table 13. Pulmonary Edema Treatment Market Restraints

    Table 14. Global Pulmonary Edema Treatment Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Pulmonary Edema Treatment Market Share by Players (2018-2023)

    Table 16. Global Top Pulmonary Edema Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Edema Treatment as of 2022)

    Table 17. Ranking of Global Top Pulmonary Edema Treatment Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Pulmonary Edema Treatment Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Pulmonary Edema Treatment Product Solution and Service

    Table 21. Date of Enter into Pulmonary Edema Treatment Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Pulmonary Edema Treatment Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Pulmonary Edema Treatment Revenue Market Share by Type (2018-2023)

    Table 25. Global Pulmonary Edema Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Pulmonary Edema Treatment Revenue Market Share by Type (2024-2029)

    Table 27. Global Pulmonary Edema Treatment Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Pulmonary Edema Treatment Revenue Market Share by Application (2018-2023)

    Table 29. Global Pulmonary Edema Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Pulmonary Edema Treatment Revenue Market Share by Application (2024-2029)

    Table 31. North America Pulmonary Edema Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Pulmonary Edema Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Pulmonary Edema Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Pulmonary Edema Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Pulmonary Edema Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Pulmonary Edema Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Pulmonary Edema Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Pulmonary Edema Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Pulmonary Edema Treatment Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Pulmonary Edema Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Pulmonary Edema Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Pulmonary Edema Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Pulmonary Edema Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Pulmonary Edema Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Pulmonary Edema Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Pfizer Inc (US) Company Detail

    Table 47. Pfizer Inc (US) Business Overview

    Table 48. Pfizer Inc (US) Pulmonary Edema Treatment Product

    Table 49. Pfizer Inc (US) Revenue in Pulmonary Edema Treatment Business (2018-2023) & (US$ Million)

    Table 50. Pfizer Inc (US) Recent Development

    Table 51. ARGON MEDICAL (US) Company Detail

    Table 52. ARGON MEDICAL (US) Business Overview

    Table 53. ARGON MEDICAL (US) Pulmonary Edema Treatment Product

    Table 54. ARGON MEDICAL (US) Revenue in Pulmonary Edema Treatment Business (2018-2023) & (US$ Million)

    Table 55. ARGON MEDICAL (US) Recent Development

    Table 56. Edwards Lifesciences Corporation (US) Company Detail

    Table 57. Edwards Lifesciences Corporation (US) Business Overview

    Table 58. Edwards Lifesciences Corporation (US) Pulmonary Edema Treatment Product

    Table 59. Edwards Lifesciences Corporation (US) Revenue in Pulmonary Edema Treatment Business (2018-2023) & (US$ Million)

    Table 60. Edwards Lifesciences Corporation (US) Recent Development

    Table 61. BD (US) Company Detail

    Table 62. BD (US) Business Overview

    Table 63. BD (US) Pulmonary Edema Treatment Product

    Table 64. BD (US) Revenue in Pulmonary Edema Treatment Business (2018-2023) & (US$ Million)

    Table 65. BD (US) Recent Development

    Table 66. Alcaliber S.A. (Spain) Company Detail

    Table 67. Alcaliber S.A. (Spain) Business Overview

    Table 68. Alcaliber S.A. (Spain) Pulmonary Edema Treatment Product

    Table 69. Alcaliber S.A. (Spain) Revenue in Pulmonary Edema Treatment Business (2018-2023) & (US$ Million)

    Table 70. Alcaliber S.A. (Spain) Recent Development

    Table 71. Lupin Pharmaceuticals (India) Company Detail

    Table 72. Lupin Pharmaceuticals (India) Business Overview

    Table 73. Lupin Pharmaceuticals (India) Pulmonary Edema Treatment Product

    Table 74. Lupin Pharmaceuticals (India) Revenue in Pulmonary Edema Treatment Business (2018-2023) & (US$ Million)

    Table 75. Lupin Pharmaceuticals (India) Recent Development

    Table 76. Vitaltec Corporation (China) Company Detail

    Table 77. Vitaltec Corporation (China) Business Overview

    Table 78. Vitaltec Corporation (China) Pulmonary Edema Treatment Product

    Table 79. Vitaltec Corporation (China) Revenue in Pulmonary Edema Treatment Business (2018-2023) & (US$ Million)

    Table 80. Vitaltec Corporation (China) Recent Development

    Table 81. Medtronic (US) Company Detail

    Table 82. Medtronic (US) Business Overview

    Table 83. Medtronic (US) Pulmonary Edema Treatment Product

    Table 84. Medtronic (US) Revenue in Pulmonary Edema Treatment Business (2018-2023) & (US$ Million)

    Table 85. Medtronic (US) Recent Development

    Table 86. Koninklijke Philips N.V. (The Netherlands) Company Detail

    Table 87. Koninklijke Philips N.V. (The Netherlands) Business Overview

    Table 88. Koninklijke Philips N.V. (The Netherlands) Pulmonary Edema Treatment Product

    Table 89. Koninklijke Philips N.V. (The Netherlands) Revenue in Pulmonary Edema Treatment Business (2018-2023) & (US$ Million)

    Table 90. Koninklijke Philips N.V. (The Netherlands) Recent Development

    Table 91. Siemens Healthcare (Germany) Company Detail

    Table 92. Siemens Healthcare (Germany) Business Overview

    Table 93. Siemens Healthcare (Germany) Pulmonary Edema Treatment Product

    Table 94. Siemens Healthcare (Germany) Revenue in Pulmonary Edema Treatment Business (2018-2023) & (US$ Million)

    Table 95. Siemens Healthcare (Germany) Recent Development

    Table 96. Hitachi Medical Corporation (US) Company Detail

    Table 97. Hitachi Medical Corporation (US) Business Overview

    Table 98. Hitachi Medical Corporation (US) Pulmonary Edema Treatment Product

    Table 99. Hitachi Medical Corporation (US) Revenue in Pulmonary Edema Treatment Business (2018-2023) & (US$ Million)

    Table 100. Hitachi Medical Corporation (US) Recent Development

    Table 101. Canon Medical Systems Corporation (Japan) Company Detail

    Table 102. Canon Medical Systems Corporation (Japan) Business Overview

    Table 103. Canon Medical Systems Corporation (Japan) Pulmonary Edema Treatment Product

    Table 104. Canon Medical Systems Corporation (Japan) Revenue in Pulmonary Edema Treatment Business (2018-2023) & (US$ Million)

    Table 105. Canon Medical Systems Corporation (Japan) Recent Development

    Table 106. Research Programs/Design for This Report

    Table 107. Key Data Information from Secondary Sources

    Table 108. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Pulmonary Edema Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Pulmonary Edema Treatment Market Share by Type: 2022 VS 2029

    Figure 3. Diagnosis Features

    Figure 4. Treatment Features

    Figure 5. Global Pulmonary Edema Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Pulmonary Edema Treatment Market Share by Application: 2022 VS 2029

    Figure 7. Hospitals and Clinics Case Studies

    Figure 8. Academic Institutes Case Studies

    Figure 9. Retail Pharmacies Case Studies

    Figure 10. Household Case Studies

    Figure 11. Other Case Studies

    Figure 12. Pulmonary Edema Treatment Report Years Considered

    Figure 13. Global Pulmonary Edema Treatment Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Pulmonary Edema Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Pulmonary Edema Treatment Market Share by Region: 2022 VS 2029

    Figure 16. Global Pulmonary Edema Treatment Market Share by Players in 2022

    Figure 17. Global Top Pulmonary Edema Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Edema Treatment as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Pulmonary Edema Treatment Revenue in 2022

    Figure 19. North America Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Pulmonary Edema Treatment Market Share by Country (2018-2029)

    Figure 21. United States Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Pulmonary Edema Treatment Market Share by Country (2018-2029)

    Figure 25. Germany Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Pulmonary Edema Treatment Market Share by Region (2018-2029)

    Figure 33. China Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Pulmonary Edema Treatment Market Share by Country (2018-2029)

    Figure 41. Mexico Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Pulmonary Edema Treatment Market Share by Country (2018-2029)

    Figure 45. Turkey Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Pulmonary Edema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Pfizer Inc (US) Revenue Growth Rate in Pulmonary Edema Treatment Business (2018-2023)

    Figure 48. ARGON MEDICAL (US) Revenue Growth Rate in Pulmonary Edema Treatment Business (2018-2023)

    Figure 49. Edwards Lifesciences Corporation (US) Revenue Growth Rate in Pulmonary Edema Treatment Business (2018-2023)

    Figure 50. BD (US) Revenue Growth Rate in Pulmonary Edema Treatment Business (2018-2023)

    Figure 51. Alcaliber S.A. (Spain) Revenue Growth Rate in Pulmonary Edema Treatment Business (2018-2023)

    Figure 52. Lupin Pharmaceuticals (India) Revenue Growth Rate in Pulmonary Edema Treatment Business (2018-2023)

    Figure 53. Vitaltec Corporation (China) Revenue Growth Rate in Pulmonary Edema Treatment Business (2018-2023)

    Figure 54. Medtronic (US) Revenue Growth Rate in Pulmonary Edema Treatment Business (2018-2023)

    Figure 55. Koninklijke Philips N.V. (The Netherlands) Revenue Growth Rate in Pulmonary Edema Treatment Business (2018-2023)

    Figure 56. Siemens Healthcare (Germany) Revenue Growth Rate in Pulmonary Edema Treatment Business (2018-2023)

    Figure 57. Hitachi Medical Corporation (US) Revenue Growth Rate in Pulmonary Edema Treatment Business (2018-2023)

    Figure 58. Canon Medical Systems Corporation (Japan) Revenue Growth Rate in Pulmonary Edema Treatment Business (2018-2023)

    Figure 59. Bottom-up and Top-down Approaches for This Report

    Figure 60. Data Triangulation

    Figure 61. Key Executives Interviewed